Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Anticancer, attainment, authorize, bone, British, care, carrier, Chair, claim, classification, clinician, CRi, daunorubicin, decrease, discharge, Discovery, doubt, equal, formula, heavily, ID, imaging, incomplete, invited, Journal, lecture, manuscript, marrow, NCT, Northwestern, Olsztyn, paired, population, profitable, reacquisition, RECIST, recoverability, recovery, referenced, reimbursed, reimbursement, rely, replaced, SAE, satisfaction, Science, settled, standard, topline, typically, unable, Union, unrelated, withdrawn, World
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view